News FDA Approves Lotemax SM For Ocular Surgery Pain, Inflammation by Medscape • 2019/02/25 • 0 Comments The FDA has approved a new formulation of loteprednol etabonate ophthalmic gel (Lotemax SM, Bausch + Lomb) 0.38% for postoperative inflammation and pain following ocular surgery. FDA Approvals Full Story →